MedTrace Logo

Formula Identification (FID) 114657 in Contact Lens Wearers

NCT02293538 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 234

Last updated 2016-10-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the thickness of the pre-lens tear lipid layer after 2 hours of lens wear with use of FID 114657 compared to saline control.

Conditions

  • Refractive Error

Interventions

DRUG

FID 114657 eye drops (10 ml)

Lubricating eye drop for temporary relief of burning and irritation due to dryness of the eye

DRUG

Saline control eye drops (15 ml)

Saline eye drops (15 ml)

DEVICE

Habitual contact lenses

Commercially marketed biweekly or monthly replacement soft contact lenses as prescribed by eye care practitioner, brand and power

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Clinical Manager, Pharmaceuticals, Global Medical Affairs · Alcon Research

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-07-31
Completion
2015-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02293538 on ClinicalTrials.gov